Tufts University School of Medicine, Boston, MA, USA.
Department of Orthopedic Surgery, Tufts Medical Center, Boston, MA, USA.
J Shoulder Elbow Surg. 2022 Oct;31(10):e480-e489. doi: 10.1016/j.jse.2022.04.018. Epub 2022 May 20.
The treatment of proximal humerus fracture dislocations can be challenging given the extensive injury to the proximal humeral anatomy and increased risk of devascularization of the humeral head often seen in these injuries. The purpose of this study is to undertake a systematic review of the literature on the functional outcomes, rate of revision, and short- and long-term complications for proximal humerus fracture dislocations treated with open reduction and internal fixation (ORIF).
The PubMed and OVID Embase databases were queried for literature reporting on proximal humerus fracture dislocations treated with ORIF. Data including study design, patient demographics, functional outcomes, and complications were recorded.
Twelve studies including 294 patients with Neer type 2-, 3-, or 4-part proximal humerus fracture dislocations met the criteria for inclusion. The mean patient age was 53.4 years (19-89 years) with an average follow-up of 2.9 years (1.15-4.9 years). At the final follow-up, the mean Constant score was 73.2 (52-87.3) and the mean Disabilities of the Arm Shoulder and Hand score was 26.6 (17.5-32). Avascular necrosis was observed in 20.0% (0%-82.3%) and nonunion was observed in 3.0% (0%-7.7%) of patients. Conversion to arthroplasty was observed in 10.7% (5%-20%) and a total reoperation was observed in 35.6% (11.8%-89.1%) of patients in studies explicitly reporting these outcomes. In addition to conversion to arthroplasty, common causes of reoperation were revision ORIF (5.2%) and hardware removal (22.2%).
Patients undergoing ORIF for proximal humerus fracture dislocations have reasonable functional outcomes but relatively high avascular necrosis and reoperation rates. This information can be used to counsel patients and set expectations about the potential for further surgeries.
由于肱骨近端解剖结构广泛损伤以及这些损伤中常见的肱骨头血供减少风险增加,肱骨近端骨折脱位的治疗具有挑战性。本研究的目的是对接受切开复位内固定(ORIF)治疗的肱骨近端骨折脱位的文献进行系统回顾,以评估其功能结果、翻修率以及短期和长期并发症。
在 PubMed 和 OVID Embase 数据库中查询有关接受 ORIF 治疗的肱骨近端骨折脱位的文献。记录的数据包括研究设计、患者人口统计学、功能结果和并发症。
符合纳入标准的有 12 项研究,共纳入 294 例 Neer 2 型、3 型或 4 型肱骨近端骨折脱位患者。患者平均年龄为 53.4 岁(19-89 岁),平均随访时间为 2.9 年(1.15-4.9 年)。在最终随访时,平均 Constant 评分 73.2(52-87.3),平均上肢残疾评分 26.6(17.5-32)。20.0%(0%-82.3%)的患者发生缺血性坏死,3.0%(0%-7.7%)的患者发生骨不连。10.7%(5%-20%)的患者需要行关节置换术,明确报告这些结果的研究中有 35.6%(11.8%-89.1%)的患者需要再次手术。除了关节置换术,再次手术的常见原因还有翻修 ORIF(5.2%)和内固定取出(22.2%)。
接受 ORIF 治疗的肱骨近端骨折脱位患者功能结果尚可,但缺血性坏死和再次手术率较高。这些信息可用于向患者提供咨询并对进一步手术的可能性进行预期管理。